×

Express Scripts selects AbbVie over Gilead

9:16 AM ET Mon, 22 Dec 2014

CNBC's Jim Cramer and David Faber discuss Express Scripts' selection of AbbVie over Gilead for its hepatitis C drug and what this means for Gilead.